🇺🇸 FDA
Patent

US 12311017

Identification of immunologically protective neo-epitopes for the treatment of cancers

granted A61KA61K2039/505A61K2039/70

Quick answer

US patent 12311017 (Identification of immunologically protective neo-epitopes for the treatment of cancers) held by UNIVERSITY OF CONNECTICUT expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2039/70, A61K39/0011, A61K39/395